The role of AhR in inflammatory and autoimmune diseases, particularly in colitis and MS, is receiving significant recognition, which means that there is substantial opportunity to target AhR using ligands to prevent and treat inflammatory and autoimmune diseases. This evidence concerns the gene AHR and colitis.